CIAM
HCAT icon

Caitong International Asset Management’s Health Catalyst HCAT Stock Holding History

Caitong International Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93K Sell
1,474
-66,155
-98% -$95.5K ﹤0.01% 1356
2026
Q1 		$85.9K Buy
67,629
+58,468
+638% +$110K 0.02% 625
2025
Q4 		$21.9K Buy
+9,161
New +$25.1K 0.01% 965

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitong International Asset Management's HCAT Position: Q2 2026 in Review

Caitong International Asset Management reduced its Health Catalyst (HCAT) stake by 98% in Q2 2026, selling an estimated $95.5K and leaving 1,474 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Caitong International Asset Management first reported a position in HCAT in Q4 2025 and has held it in 3 quarters since. The position peaked at $85.9K in Q1 2026. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Caitong International Asset Management held 1,474 shares of Health Catalyst worth $2.93K as of Q2 2026.
  • Caitong International Asset Management sold 66,155 Health Catalyst shares in Q2 2026, an estimated $95.5K.
  • Health Catalyst made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1356 holding.
  • Caitong International Asset Management first reported a position in Health Catalyst in Q4 2025 and has held it in 3 quarters since.
  • Caitong International Asset Management's Health Catalyst position peaked at $85.9K in Q1 2026.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.